Introduction to Non Central Nervous
Sentence Examples
Discover more insights into Non Central Nervous
Keywords frequently search together with Non Central Nervous
Narrow sentence examples with built-in keyword filters
Non Central Nervous sentence examples within cancer related cognitive
Introduction Cancer-related cognitive impairment (CRCI) is one of the most frequent and worrying side effects experienced by non-central nervous system (CNS) cancer survivors, generally related to cancer treatments.
Full Text
Cancer-related cognitive impairment (CRCI) refers to a series of cognitive impairment symptoms associated with alternations in brain structure and function, caused by a non-central nervous system malignant tumor and its related treatment.
Full Text
Non Central Nervous sentence examples within central nervous system
Literaturelly, the expression of ALK gene in IMT is very rare in central nervous system, while is relative common in non-central nervous system.
Full Text
In the drug discovery process, the blood-brain barrier (BBB) permeability plays a critical role for central nervous system active drugs candidates as well as non-central nervous system active drugs.
Full Text
Non Central Nervous sentence examples within system systemic embolism
The primary composite effectiveness outcome of stroke, non-central nervous system systemic embolism, and myocardial infarction occurred at an incidence (95% confidence interval) of 1.
Full Text
6 events per 100 patient-years), and stroke/non-central nervous system systemic embolism/myocardial infarction (3.
Full Text
Learn more from Non Central Nervous
Additionally, there were 4 regulatory approvals for non-central nervous system (CNS) cancers that described clinical outcomes for patients with brain metastases.
Full Text
The primary composite effectiveness outcome of stroke, non-central nervous system systemic embolism, and myocardial infarction occurred at an incidence (95% confidence interval) of 1.
Full Text
Characteristics of those enrolled included: median age 68 years, female/male 4/13, squamous/non-squamous 2/15, median number of non-central nervous system (CNS) metastatic sites 2 (1-5), median number of non-CNS metastatic lesions 2 (1-9), CNS involvement 6/17 (35.
Full Text
Results A 73-year-old woman with a history of non-central nervous system (CNS) involving diffuse large B-cell lymphoma (DLBCL) was referred for worsening blurry vision—visual acuity of count figures at 2 ft—in her right eye for 8 months.
Full Text
Many non-central nervous system (CNS) cancer survivors experience cognitive symptoms, which may affect their self-perceived work ability.
Full Text
Introduction Cancer-related cognitive impairment (CRCI) is one of the most frequent and worrying side effects experienced by non-central nervous system (CNS) cancer survivors, generally related to cancer treatments.
Full Text
Twenty-four patients with non-central nervous system (CNS) infections as a control group were admitted to our hospital.
Full Text
This review article discusses the composition and interactions among neural lineage and non-central nervous system cell types in brain organoids, current studies, and future perspectives in brain organoid research.
Full Text
Methods: Forty-three Ccs of non-central nervous system cancers and 43 healthy controls, aged 7–16 years, were examined.
Full Text
Pediatric non-central nervous system (CNS) malignant rhabdoid tumors (MRTs) are rare and aggressive malignancies without standard treatment strategies.
Full Text
Although non-central nervous system solid tumors (NCSTs) account for approximately 40% of all pediatric cancers, there have been few studies on endocrine complications associated with NCSTs.
Full Text
Cancer-related cognitive impairment (CRCI) refers to a series of cognitive impairment symptoms associated with alternations in brain structure and function, caused by a non-central nervous system malignant tumor and its related treatment.
Full Text
The levels were compared with CSF samples of 4 children with noninfectious causes of accidental death and 11 controls with non-central nervous system illnesses without fatal episodes.
Full Text
Many patients treated with chemotherapy for non-central nervous system (CNS) cancers experience cognitive dysfunction.
Full Text
Cancer- and treatment-related cognitive dysfunction (CRCD) is a common challenge faced by patients diagnosed with non-central nervous system (CNS) cancer.
Full Text
In addition, there is no universally accepted protocol for managing osseous LCH for single non-central nervous system-risk lesions.
Full Text
Forty-one percent had a non-central nervous system (CNS) solid tumor.
Full Text
Patients with non-central nervous system (CNS) cancer frequently report cognitive complaints, that are recurrent and affect their quality of life.
Full Text
Many systemic sGC stimulators have been characterized and advanced into clinical development for a variety of non-central nervous system (CNS) pathologies.
Full Text
Methods We identified patients followed at the Childhood Cancer Survivor Clinic, Stollery Children’s Hospital who had a history of non-central nervous system malignancies and received cranial irradiation who developed meningiomas between clinic inception in 1971 and June 2013.
Full Text
Methods We obtained 2,020 PCNSL participants and 88,613 non-central nervous system lymphoma (NCNSL) participants with chemotherapy from Surveillance, Epidemiology, and End Results (SEER) database from 2004 to 2015.
Full Text
The primary efficacy endpoint is a composite of symptomatic venous thromboembolism, myocardial infarction, ischemic stroke, acute limb ischemia, non-central nervous systemic embolization, all-cause hospitalization, and all-cause mortality.
Full Text
Adults with non-central nervous system (CNS) cancers frequently report problems in attention, memory and executive function during or after chemotherapy, referred to as cancer-related cognitive dysfunction (CRCD).
Full Text
Cancer-related cognitive impairment (CRCI) has been reported in non-central nervous system neoplasms survivors.
Full Text
Literaturelly, the expression of ALK gene in IMT is very rare in central nervous system, while is relative common in non-central nervous system.
Full Text
Positive serological markers and non-central nervous system systemic diseases were associated with non-lymphomatous diseases.
Full Text
Our objective was to evaluate the effect on brain metabolism in pediatric patients with non-central nervous system cancer treated with chemotherapy by analyzing brain data from serial whole-body fluorodeoxyglucose positron emission tomography/computed-tomography (FDG-PET/CT) scans taken before and sequentially after therapy.
Full Text
6 events per 100 patient-years), and stroke/non-central nervous system systemic embolism/myocardial infarction (3.
Full Text
1%) patients exhibited non-central nervous system infection (Ngroup).
Full Text
Here, we review the use of these human cellular models to study cell-cell interactions among progenitors, neurons, astrocytes, oligodendrocytes, cancer cells, and non-central nervous system cell types, as well as efforts to study connectivity between brain regions following controlled assembly of organoids.
Full Text
28] and composite of stroke (ischemic or hemorrhagic)/non-central nervous system (non-CNS) systemic embolism (SE)/myocardial infarction (MI) (2.
Full Text
BackgroundPrevious neurocognitive assessments in non-central nervous system cancers highlight the high incidence of neurocognitive dysfunction in this study population.
Full Text
In the drug discovery process, the blood-brain barrier (BBB) permeability plays a critical role for central nervous system active drugs candidates as well as non-central nervous system active drugs.
Full Text
Tumor location was classified into three categories: 30 pleuropulmonary, 96 non-pleuropulmonary/non-central nervous system (CNS), and 18 CNS tumors.
Full Text
Recently, we found that NEGR1 is involved in intracellular cholesterol trafficking, suggesting that it performs a non-central nervous system (CNS) function associated with human obesity.
Full Text
Purpose To report an atypical case of vitreoretinal lymphoma, secondary to non-central nervous system (non-CNS) systemic lymphoma, masquerading as an infectious retinitis.
Full Text
However, cancer-related cognitive impairment (CRCI) is frequently reported in patients treated for non-central nervous system cancers, particularly during and after chemotherapy.
Full Text
Five definitive and six probable cases of neurocysticercosis (NCC), and two cases of non-central nervous system cysticercosis (non-CNS CC) were identified.
Full Text
Cognitive impairment is common for chronic cardiovascular diseases, both central nervous system and non-central nervous system cancer, chronic lung diseases, diabetes, and presented mostly from mild to moderate form.
Full Text
BACKGROUND
An emerging body of research suggests that non-central nervous system (CNS) cancer may negatively impact the brain apart from effects of cancer treatment.
Full Text
The patients were divided into 2 groups: central nervous system risk craniofacial bone involvement group(CNS-RISK) and non-central nervous system risk craniofacial bone involvement group(non-CNS-RISK).
Full Text
Primary endpoints were any bleeding and a composite of stroke/non-central nervous system systemic embolism (non-CNS SE)/myocardial infarction (MI).
Full Text
However, cancer-related cognitive impairment (CRCI) is frequently reported in patients treated for non-central nervous system cancers, particularly during and after chemotherapy.
Full Text
BACKGROUND: As the treatment of non-central nervous system (CNS) malignancies has improved, brain metastases (BM) have been observed as a site of first recurrence in patients with controlled or responding systemic cancers.
Full Text
These brief proprioceptive and haptic assessments were utilized to characterize somatosensory impairment in 15 individuals treated with vinca alkaloid-containing chemotherapy regimens for non-central nervous system (CNS) pediatric cancers (ages 6-25 years).
Full Text
The aim of this paper was to systematically review available literature on structural brain alterations following adult non-central nervous system (CNS) cancers and associated treatments.
Full Text
However, recent studies show that a significant portion of patients with non-central nervous system (CNS) tumors experience cognitive decline prior to treatment, suggesting a role for tumor-derived factors in modulating cognition and behavior.
Full Text
Combination aspirin and clopidogrel reduces risk of recurrent ischemic stroke, but was also associated with risk of non-central nervous system (CNS) major bleeding in the Platelet-Oriented Inhibiti.
Full Text
e13590Background: As the treatment of non-central nervous system (CNS) malignancies improves, brain metastases (BM) are occurring more often in patients with controlled primary disease.
Full Text
The authors paid specific attention to localization: pleuropulmonary, nonpleuropulmonary/non-central nervous system and central nervous system.
Full Text
Stroke/non-central nervous system systemic embolism/myocardial infarction was observed in 144 patients (1.
Full Text